Dr. Markus Bauer received his PhD from the Free University in Berlin while being a member of the International Max Planck Research School for Computational Biology and Scientific Computing. After working several years as a bioinformatics scientist at Illumina, he joined Boehringer Ingelheim as a distinguished scientist.

Area of Expertise: 
Pharmaceutical (Drug discovery, high throughput sequencing)
Working Group: